‘Omics’ Approaches to Understanding Interstitial Cystitis/Painful Bladder Syndrome/Bladder Pain Syndrome

키워드

참고문헌 (78)

1. Persu C, "From interstitial cystitis to chronic pelvic pain", J Med Life, 3, pp.167~174 (2010)
2. Phatak S, "The management of interstitial cystitis: an update", Nat Clin Pract Urol, 3, pp.45~53 (2006)
3. Hanno P, "Diagnosis of interstitial cystitis", J Urol, 143, pp.278~281 (1990)
4. Anger JT, "Treatment choice, duration, and cost in patients with interstitial cystitis and painful bladder syndrome", Int Urogynecol J, 22, pp.395~400 (2011)
5. Hanno P, "International Consultation on IC - Rome, September 2004", Forging an International Consensus: progress in painful bladder syndrome, Int Urogynecol J Pelvic Floor Dysfunct, pp.2005, 16(Suppl 1)[DOI]
6. Ness TJ, "Psychophysical evidence of hypersensitivity in subjects with interstitial cystitis", J Urol, 173, pp.1983~1987 (2005)
7. Nordling J, "Primary evaluation of patients suspected of having interstitial cystitis (IC)", Eur Urol, 45, pp.662~669 (2004)
8. Hanno PM, "AUA guideline for the diagnosis and treatment of interstitial cystitis", bladder pain syndrome, 2011, pp.185, 2162~2170
9. Hanno PM, "Analysis of long-term Elmiron therapy for interstitial cystitis", Urology, 49(5A Suppl), pp.93~99 (1997)
10. Keay S, "Decreased in vitro proliferation of bladder epithelial cells from patients with interstitial cystitis", Urology, 61, pp.1278~1284 (2003)
11. Slobodov G, "Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis", J Urol, 171, pp.1554~1558 (2004)
12. Zhang CO, "Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from patients with interstitial cystitis", J Urol, 174, pp.2382~2387 (2005)
13. Ochodnicky P, "Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target", Neurourol Urodyn, 30, pp.1227~1241 (2011)
14. Liu HT, "Urinary nerve growth factor levels in overactive bladder syndrome and lower urinary tract disorders", J Formos Med Assoc, 109, pp.862~878 (2010)
15. Chung SD, "Elevation of serum c-reactive protein in patients with OAB and IC", BPS implies chronic inflammation in the urinary bladder, 2011, pp.30, 417~420
16. Kiuchi H, "Increased vascular endothelial growth factor expression in patients with bladder pain syndrome", interstitial cystitis: its association with pain severity and, 2009, pp.104, 826~831
17. Tamaki M, "Possible mechanisms inducing glomerulations in interstitial cystitis: relationship between endoscopic findings and expression of angiogenic growth factors", J Urol, 172, pp.945~948 (2004)
18. Li J, "Inflammation in the uterus induces phosphorylated extracellular signal-regulated kinase and substance P immunoreactivity in dorsal root ganglia neurons innervating both uterus and colon in rats", J Neurosci Res, 86, pp.2746~2752 (2008)
19. Keay SK, "An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide", Proc Natl Acad Sci U S A, 101, pp.11803~11808 (2004)
20. Keay S, "Concentrations of specific epithelial growth factors in the urine of interstitial cystitis patients and controls", J Urol, 158, pp.1983~1988 (1997)
21. Keay S, "A diagnostic in vitro urine assay for interstitial cystitis", Urology, 52, pp.974~978 (1998)
22. Keay S, "Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor: sensitive and specific urine markers for interstitial cystitis", Urology, 57(6 Suppl 1), pp.104~ (2001)
23. Kim J, "p53 mediates interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human urothelial cells", FEBS Lett, 581, pp.3795~3799 (2007)
24. Keay S, "Cell signaling in interstitial cystitis", painful bladder syndrome, 2008, pp.20, 2174~2179
25. Kim J, "Heparin-binding epidermal growth factor-like growth factor functionally antagonizes interstitial cystitis antiproliferative factor via mitogen-activated protein kinase pathway activation", BJU Int, 103, pp.541~546 (2009)
26. 김자영, "Antiproliferative Factor Signaling and Interstitial Cystitis", Painful Bladder Syndrome, 2011, pp.15(4), 184~191[DOI]
27. Yang W, "Quantitative Proteomics Identifies a beta-Catenin Network as an Element of the Signaling Response to Frizzled-8 Protein-Related Antiproliferative Factor", MOLECULAR & CELLULAR PROTEOMICS, 10(0000000006) (2011), AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
28. Kim J, "An hTERT-immortalized human urothelial cell line that responds to anti-proliferative factor", In Vitro Cell Dev Biol Anim, 47, pp.2~9 (2011)
29. Simon LJ, "The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics", Urology, 49(5A Suppl), pp.64~75 (1997)
30. van de Merwe JP, "Systemic aspects of interstitial cystitis, immunology and linkage with autoimmune disorders", Int J Urol, (10 Suppl), pp.S35~S38 (2003)
31. Sugaya K, "Molecular analysis of adrenergic receptor genes and interleukin-4", interleukin-4 receptor genes in patients with interstitial cystitis, 2002, pp.168, 2668~2671
32. Dimitrakov JD, "A case of familial clustering of interstitial cystitis and chronic pelvic pain syndrome", Urology, 58, pp.281~ (2001)
33. "J Urol", 2005, 84~
34. Sebat J, "Large-scale copy number polymorphism in the human genome", Science, 305, pp.525~528 (2004)
35. Tuzun E, "Fine-scale structural variation of the human genome", Nat Genet, 37, pp.727~732 (2005)
36. Shoskes DA, "Cytokine polymorphisms in men with chronic prostatitis", chronic pelvic pain syndrome: association with diagnosis and treatment response, 2002, pp.168, 331~335
37. Ritchie MD, "Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer", Am J Hum Genet, 69, pp.138~147 (2001)
38. Farrah T, "A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas", Mol Cell Proteomics, 10, pp.M110006353~ (2011)
39. Deutsch EW, "Human Plasma Peptide Atlas", Proteomics, 5, pp.3497~3500 (2005)
40. Aebersold R, "Mass spectrometry-based proteomics", Nature, 422, pp.198~207 (2003)
41. Hutchens TW, "New desorption strategies for the mass-spectrometric analysis of macromolecules", Rapid Commun Mass Spectrom, 7, pp.576~580 (1993)
42. Van QN, "The use of urine proteomic and metabonomic patterns for the diagnosis of interstitial cystitis and bacterial", Dis Markers, 19, pp.169~183 (2004)
43. Rabilloud T, "Two-dimensional gel electrophoresis in proteomics: Past, present and future", J Proteomics, 73, pp.2064~2077 (2010)
44. Unlu M, "Difference gel electrophoresis: a single gel method for detecting changes in protein extracts", Electrophoresis, 18, pp.2071~2077 (1997)
45. Canter MP, "Proteomic techniques identify urine proteins that differentiate patients with interstitial cystitis from asymptomatic control subjects", Am J Obstet Gynecol, 198(553), pp.e1~e6 (2008)
46. Kuromitsu S, "Increased concentration of neutrophil elastase in urine from patients with interstitial cystitis", Scand J Urol Nephrol, 42, pp.455~461 (2008)
47. Lemberger SI, "Decrease of Trefoil factor 2 in cats with feline idiopathic cystitis", BJU Int, 107, pp.670~677 (2011)
48. Nagaraj N, "Deep proteome and transcriptome mapping of a human cancer cell line", Mol Syst Biol, 7, pp.548~ (2011)
49. Beck M, "The quantitative proteome of a human cell line", Mol Syst Biol, 7, pp.549~ (2011)
50. Wisniewski JR, "Proteomic workflow for analysis of archival formalin fixed and paraffin embedded clinical samples to a depth of 10,000 proteins", Proteomics Clin Appl (2012)
51. Goo YA, "Urinary proteomics evaluation in interstitial cystitis", painful bladder syndrome: a pilot study, 2010, pp.36, 464~478
52. Huttenhain R, "Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics", Sci Transl Med, 4, pp.142~194 (2012)
53. Fukui Y, "A metabonomic approach identifies human urinary phenylacetylglutamine as a novel marker of interstitial cystitis", J Chromatogr B Analyt Technol Biomed Life Sci, 877, pp.3806~3812 (2009)
54. Smolinska A, "NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review", Anal Chim Acta, 750, pp.82~97 (2012)
55. Barding GA Jr, "Quantitative NMR for bioanalysis and metabolomics", Anal Bioanal Chem, 404, pp.1165~1179 (2012)
56. Auffray C, "Systems medicine: the future of medical genomics and healthcare", Genome Med, 1, pp.2~ (2009)
57. Yang W, "Integration analysis of quantitative proteomics and transcriptomics data identifies potential targets of frizzled-8 protein-related antiproliferative factor in vivo", BJU International, 0(0), pp.0~0 (2012), Blackwell Publishing
58. Hwang D, "A data integration methodology for systems biology", Proc Natl Acad Sci U S A, 102, pp.17296~17301 (2005)
59. Alon U, "Biological networks: the tinkerer as an engineer", Science, 301, pp.1866~1867 (2003)
60. Barabasi AL, "Network medicine: a network-based approach to human disease", Nat Rev Genet, 12, pp.56~68 (2011)
61. Gentleman RC, "Bioconductor: open software development for computational biology and bioinformatics", Genome Biol, 5, pp.R80~ (2004)
62. Huang da W, "Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources", Nat Protoc, 4, pp.44~57 (2009)
63. Huang da W, "Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists", Nucleic Acids Res, 37, pp.1~13 (2009)
64. Subramanian A, "Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles", Proc Natl Acad Sci U S A, 102, pp.15545~15550 (2005)
65. Nakazato T, "Gendoo: functional profiling of gene and disease features using MeSH vocabulary", Nucleic Acids Res, 37, pp.W166~W169 (2009)
66. Wall DP, "Genotator: a disease-agnostic tool for genetic annotation of disease", BMC Med Genomics, 3, pp.50~ (2010)
67. Xia J, "MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data", Nucleic Acids Res, 38, pp.W71~W77 (2010)
68. Aranda B, "PSICQUIC and PSISCORE: accessing and scoring molecular interactions", Nat Methods, 8, pp.528~529 (2011)
69. von Mering C, "STRING: a database of predicted functional associations between proteins", Nucleic Acids Res, 31, pp.258~261 (2003)
70. Shannon P, "Cytoscape: a software environment for integrated models of biomolecular interaction networks", Genome Res, 13, pp.2498~2504 (2003)
71. Ogata H, "Kyoto Encyclopedia of Genes and Genomes", Nucleic Acids Res, 27, pp.29~34 (1999)
72. Kohler S, "Walking the interactome for prioritization of candidate disease genes", Am J Hum Genet, 82, pp.949~958 (2008)
73. Vanunu O, "Associating genes and protein complexes with disease via network propagation", PLoS Comput Biol, 6, pp.e1000641~ (2010)
74. Taylor IW, "Dynamic modularity in protein interaction networks predicts breast cancer outcome", Nat Biotechnol, 27, pp.199~204 (2009)
75. Carro MS, "The transcriptional network for mesenchymal transformation of brain tumours", Nature, 463, pp.318~325 (2010)
76. Gamper M, "Gene expression profile of bladder tissue of patients with ulcerative interstitial cystitis", BMC Genomics, 10, pp.199~ (2009)
77. Blalock EM, "Gene expression analysis of urine sediment: evaluation for potential noninvasive markers of interstitial cystitis", bladder pain syndrome, 2012, pp.187, 725~732
78. "J Urol", 2009, 563~

관련 논문AI추천